Alzheimer's disease

This nutrient deficiency linked to organ damage and Alzheimer’s disease

Choline is an essential nutrient that our bodies need to stay healthy. Although the liver makes a small amount, we get most of it...

New drug can reduce stroke damage and treat Alzheimer’s

Stroke is one of the leading causes of death around the world, second only to heart disease. A team of researchers in Japan has...

Why Alzheimer’s affects some brain areas more than others

Researchers from the University of California, San Francisco (UCSF) have uncovered new insights into how Alzheimer’s disease spreads in the brain and why certain...

Rosemary compound shows promise for Alzheimer’s treatment

Rosemary has long been linked to memory. In Shakespeare’s Hamlet, the character Ophelia says, “There’s rosemary, that’s for remembrance.” Now, modern science is taking a...

Living through the pandemic may have aged people’s brains

A new study from the University of Nottingham has found that simply living through the Covid-19 pandemic may have aged people’s brains—even if they...

Experimental drug delays Alzheimer’s in high-risk people

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s,...

Old vaccine shows new promise in fighting Alzheimer’s

Alzheimer’s disease is a type of dementia that affects millions of people around the world. It slowly damages memory and thinking skills, leaving families...

Bacteria use Alzheimer’s-linked proteins as armor in microbial battles

Amyloids, the sticky proteins linked to Alzheimer’s disease, may have a surprising role outside the human brain. According to new research from the University of...

Smell test may help detect early signs of cognitive decline

A new study from researchers at Mass General Brigham has found that a simple smell test may help detect early signs of memory problems. The...

Alzheimer’s drug may work differently in men and women

Since receiving approval from the U.S. Food and Drug Administration (FDA) in 2023, the Alzheimer's drug lecanemab—sold under the brand name Leqembi—has seen steady...